The failure to provide bond-market access and other kinds of financial assistance is hampering the prospects of innovative small businesses in the UK, creating a "valley of death" between the discovery of medical innovations and bringing them to market, according to a parliamentary report. Andrew Miller, parliamentary Select Committee chairman said, "The UK's university and science sector is a global success, but the challenge for government is how that world class academic research can be translated into commercial activity."

Full Story:
PharmaTimes (U.K.)

Related Summaries